[Form 3] IceCure Medical Ltd. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

IceCure Medical Ltd. director Malca Yonatan filed an initial statement of beneficial ownership on Form 3. The provided data shows no reported transactions or derivative positions and no specific share holdings listed, indicating this is a baseline regulatory disclosure of insider status rather than a trading event.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Malca Yonatan

(Last) (First) (Middle)

7 HA'ESHEL ST., PO BOX 3163

(Street)

CAESAREA 3079504

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
IceCure Medical Ltd. [ ICCM ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Yonatan Malca	03/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the IceCure Medical (ICCM) Form 3 filing by Malca Yonatan show?

The Form 3 shows that Malca Yonatan is a director of IceCure Medical Ltd. It is an initial ownership statement, with no transactions, derivative positions, or specific share holdings reported in the provided data for this filing.

Does the IceCure Medical (ICCM) Form 3 indicate any insider buying or selling?

No, the Form 3 data shows no insider buying or selling. All transaction counts, including buys, sells, exercises, gifts, and tax withholdings, are zero, so the filing functions purely as an initial disclosure of insider status.

Are any share or option holdings reported for Malca Yonatan in the ICCM Form 3?

No specific share or option holdings are listed for Malca Yonatan. The summary indicates zero holding entries and no derivative positions, meaning the excerpt only confirms the reporting person’s role as a director without detailing current positions.

What is the purpose of a Form 3 like the one filed for IceCure Medical (ICCM)?

Form 3 is used to disclose an insider’s status when they first become a reporting person. In this case, it records that Malca Yonatan is a director of IceCure Medical Ltd., without showing any accompanying trades or detailed ownership positions in the provided data.

Does the IceCure Medical (ICCM) Form 3 mention Rule 10b5-1 trading plans or footnote qualifiers?

The data includes a placeholder footnote entry but no text describing trading plans or ownership qualifiers. As presented, the filing simply records insider status, with no additional narrative on trading arrangements or indirect ownership structures.